Psyllium Husk
A soluble fiber studied for cholesterol and digestive regularity.
Supplements
Research records
Historical source snapshot. Not freshly verified, not a recommendation. Study findings, community accounts and app defaults are not interchangeable.
Publication suitability · 2026-10-15: Historical reference only; not a clinical verification. Clinical, regulatory, efficacy, safety and dose claims are not independently established by this review.
Psyllium Husk
A soluble fiber studied for cholesterol and digestive regularity.
Evidence category: Systematic review. This describes the source category, not approval or certainty.
Regulatory statement in source: Not separately recorded; do not infer approval from the evidence category.
Psyllium is a soluble, viscous fiber derived from the husk of Plantago ovata seeds, commonly used as a bulk-forming laxative and fiber supplement. Randomized controlled trials have examined its effects on chronic constipation and on blood lipid levels including LDL cholesterol. Pooled meta-analyses of these trials report consistent improvements in stool frequency for constipation and reductions in LDL and non-HDL cholesterol compared with placebo.
Benefits reported in the imported source
- Randomized trials consistently show reductions in LDL and non-HDL cholesterol compared with control diets
- Well-supported as a bulk-forming fiber for relieving chronic constipation
Risks and limits
- Mild gastrointestinal effects such as bloating and gas are commonly reported, especially when starting
- Product adulteration with cheaper fillers such as amaranth or wheat bran has been documented in the psyllium supplement market
Source bottom line: Trial evidence solidly supports psyllium for improving cholesterol markers and relieving constipation, making it one of the better-evidenced fiber supplements on the market.
Uncertainty: Reference information only. Not medical advice.
Study protocols — reports, not instructions
Twenty-eight randomized controlled trials, 1924 participants with or without hypercholesterolemia
- Reported regimen
- Oral psyllium fiber supplementation at a median dose of about 10 grams per day for at least three weeks, compared against control diets or placebo fiber
- Duration
- At least three weeks across the twenty-eight pooled trials
- Reported outcome
- Significant reductions in LDL cholesterol, non-HDL cholesterol, and apolipoprotein B compared with control, graded as moderate to high quality evidence by the review authors
- Source
- Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B - PubMed
Claim provenance
evidence.json#/catalog:supplement:psyllium/protocols/0
Community and practice descriptions
Accounts of a practice are not evidence of safety or effectiveness. Words such as “standard”, “safe” or “recommended” describe the source account, not verified consensus or this wiki’s advice. Commercial and self-published citations are retained for traceability, not vendor endorsement or independent clinical corroboration.
Historical research outcome: no-verified-description · 2026-10-06
No suitable community description was independently verified in these checks. The entry remains empty; this does not establish that no practice exists elsewhere.
- https://my.clevelandclinic.org/health/drugs/19079-psyllium: blocked — Independent direct retrieval returned HTTP 403. No description was verified from this inaccessible response.
Pharmacokinetic context
No half-life recorded in this source snapshot. No value has been inferred.
Source references
- Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B - PubMed
- Psyllium: Benefits, Dosage, and Side Effects - Examine (availability check 2026-10-15: source not retrieved; HTTP 429)
Snapshot provenance
Source ID: catalog:supplement:psyllium. Commit: adc7684614f9439b41d91a3312b62e7982c7e20e. Review state: historical-not-reverified. Authored links are retained separately from the canonical evidence links in the public data. App templates/defaults and rejected drafts are archived, not deployed.
Related entries and components
None listed.